Rudolf Jaenisch
Jaenisch, Rudolf.
![Sudoc [ABES], France](/viaf/images/flags/SUDOC.png "Sudoc [ABES], France")
Jaenisch, Rudolf, 1942-
Rudolf Jaenisch deutscher Molekularbiologe und Genetiker
VIAF ID: 34518276 (Personal)
Permalink: http://viaf.org/viaf/34518276
Preferred Forms
-
200 _ | ‡a Jaenisch ‡b Rudolf ‡f 1942-....
-
100 1 _
‡a
Jaenisch, Rudolf
-
100 1 _ ‡a Jaenisch, Rudolf (sparse)
-
100 1 _
‡a
Jaenisch, Rudolf
-
100 1 _ ‡a Jaenisch, Rudolf
-
100 1 _
‡a
Jaenisch, Rudolf
-
100 1 _ ‡a Jaenisch, Rudolf
-
100 1 _
‡a
Jaenisch, Rudolf
-
100 1 _ ‡a Jaenisch, Rudolf
-
100 1 _
‡a
Jaenisch, Rudolf
‡d
1942-
-
100 1 _
‡a
Jaenisch, Rudolf
‡d
1942-
-
100 1 _ ‡a Jaenisch, Rudolf, ‡d 1942-
-
100 1 _ ‡a Jaenisch, Rudolf.
-
100 0 _
‡a
Rudolf Jaenisch
-
100 0 _
‡a
Rudolf Jaenisch
‡c
deutscher Molekularbiologe und Genetiker
4xx's: Alternate Name Forms (25)
5xx's: Related Names (1)
Works
| Title | Sources |
|---|---|
| ADN l'humanité sur mesure |
|
| Animal virus genetics |
|
| Beta 2-microglobulin deficient mice lack CD4-8+ cytolytic T cells. 1990. |
|
| CD8+ t cells from mice transnuclear for a TCR that recognizes a single H-2Kb-restricted MHV68 epitope derived from gB-ORF8 help control infection |
|
| Genetic manipulation of the early mammalian embryo |
|
| Genome Editing in Neurosciences |
|
| Honyurui shoki hai no idenshi sosa. |
|
| In Vitro Modeling of Complex Neurological Diseases |
|
| In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state |
|
| Ischemic brain damage in mice after selectively modifying BDNF or NT4 gene expression. |
|
| Jointly reduced inhibition and excitation underlies circuit-wide changes in cortical processing in Rett syndrome |
|
| Lack of neurotrophin-3 leads to deficiencies in the peripheral nervous system and loss of limb proprioceptive afferents |
|
| A latent pro-survival function for the mir-290-295 cluster in mouse embryonic stem cells |
|
| Lipidomic Analysis of α-Synuclein Neurotoxicity Identifies Stearoyl CoA Desaturase as a Target for Parkinson Treatment |
|
| Long-range cis effects of ectopic X-inactivation centres on a mouse autosome |
|
| Loss of methylation activates Xist in somatic but not in embryonic cells |
|
| Male and female mice derived from the same embryonic stem cell clone by tetraploid embryo complementation |
|
| Mammalian (cytosine-5) methyltransferases cause genomic DNA methylation and lethality in Drosophila. |
|
| Mammalian nuclear transfer |
|
| Matched Developmental Timing of Donor Cells with the Host Is Crucial for Chimera Formation. |
|
| Mechanisms and models of somatic cell reprogramming |
|
| MeCP2 links heterochromatin condensates and neurodevelopmental disease |
|
| MeCP2-regulated miRNAs control early human neurogenesis through differential effects on ERK and AKT signaling |
|
| Medicine. iPSC disease modeling |
|
| Mesenchymal and adrenergic cell lineage states in neuroblastoma possess distinct immunogenic phenotypes |
|
| Messenger RNAs encoding mouse histone macroH2A1 isoforms are expressed at similar levels in male and female cells and result from alternative splicing |
|
| Metastable pluripotent states in NOD-mouse-derived ESCs |
|
| MHC class I deficiency: susceptibility to natural killer |
|
| Mice cloned from olfactory sensory neurons |
|
| Mice lacking brain-derived neurotrophic factor develop with sensory deficits |
|
| Microcephaly Modeling of Kinetochore Mutation Reveals a Brain-Specific Phenotype |
|
| Microfluidic control of cell pairing and fusion |
|
| Microinjection of cloned retroviral genomes into mouse zygotes: integration and expression in the animal. |
|
| Micromanipulating dosage compensation: understanding X-chromosome inactivation through nuclear transplantation |
|
| Mir-290-295 deficiency in mice results in partially penetrant embryonic lethality and germ cell defects |
|
| Mitogenicity of DNA from different organisms for murine B cells |
|
| Modeling human neural development and diseases using pluripotent stem cells |
|
| Modélisation des maladies neurodéveloppementales humaines à l'aide de technologies innovantes : cellules souches, édition génomique et mini-cerveau. |
|
| Molecular analysis of the Mov 34 mutation: transcript disrupted by proviral integration in mice is conserved in Drosophila |
|
| Molecular control of pluripotency |
|
| Molecular Criteria for Defining the Naive Human Pluripotent State. |
|
| Monoclonal mice generated by nuclear transfer from mature B and T donor cells |
|
| Multiplexed activation of endogenous genes by CRISPR-on, an RNA-guided transcriptional activator system |
|
| Musashi-2 regulates normal hematopoiesis and promotes aggressive myeloid leukemia |
|
| Musashi proteins are post-transcriptional regulators of the epithelial-luminal cell state |
|
| Mutagenicity of 5-aza-2'-deoxycytidine is mediated by the mammalian DNA methyltransferase |
|
| Mutations in T-cell antigen receptor genes alpha and beta block thymocyte development at different stages |
|
| n80130492 |
|
| Nanoparticles for gene transfer to human embryonic stem cell colonies |
|
| Neurons derived from reprogrammed fibroblasts functionally integrate into the fetal brain and improve symptoms of rats with Parkinson's disease |
|
| Neurotrophin-3 and trkC in muscle are non-essential for the development of mouse muscle spindles |
|
| Neurotrophin-3 modulates noradrenergic neuron function and opiate withdrawal |
|
| Neurotrophin-3 promotes cell death induced in cerebral ischemia, oxygen-glucose deprivation, and oxidative stress: possible involvement of oxygen free radicals |
|
| New advances in iPS cell research do not obviate the need for human embryonic stem cells |
|
| Non-CpG methylation is prevalent in embryonic stem cells and may be mediated by DNA methyltransferase 3a. |
|
| Non-imprinted Igf2r expression decreases growth and rescues the Tme mutation in mice. |
|
| Normal development and growth of mice carrying a targeted disruption of the alpha 1 retinoic acid receptor gene |
|
| Normal epithelial branching morphogenesis in the absence of collagen I |
|
| Normal eye-specific patterning of retinal inputs to murine subcortical visual nuclei in the absence of brain-derived neurotrophic factor |
|
| NT-3 facilitates hippocampal plasticity and learning and memory by regulating neurogenesis |
|
| Nuclear cloning and direct reprogramming: the long and the short path to Stockholm |
|
| Nuclear cloning, epigenetic reprogramming and cellular differentiation. |
|
| Nuclear cloning of embryonal carcinoma cells |
|
| Nuclear transplantation, embryonic stem cells, and the potential for cell therapy |
|
| Nuclear transplantation: lessons from frogs and mice |
|
| OCT4 cooperates with distinct ATP-dependent chromatin remodelers in naïve and primed pluripotent states in human |
|
| Oct4 expression is not required for mouse somatic stem cell self-renewal |
|
| On the cloning of animals from terminally differentiated cells |
|
| Opposing effects of DNA hypomethylation on intestinal and liver carcinogenesis |
|
| Optimal-Transport Analysis of Single-Cell Gene Expression Identifies Developmental Trajectories in Reprogramming |
|
| p75-deficient embryonic dorsal root sensory and neonatal sympathetic neurons display a decreased sensitivity to NGF |
|
| p75-deficient trigeminal sensory neurons have an altered response to NGF but not to other neurotrophins |
|
| Pan-Src family kinase inhibitors replace Sox2 during the direct reprogramming of somatic cells |
|
| Parent-of-Origin DNA Methylation Dynamics during Mouse Development |
|
| Parental origin-specific expression of Mash2 is established at the time of implantation with its imprinting mechanism highly resistant to genome-wide demethylation. |
|
| Parkinson-associated risk variant in distal enhancer of α-synuclein modulates target gene expression |
|
| Parkinson-causing α-synuclein missense mutations shift native tetramers to monomers as a mechanism for disease initiation |
|
| Parkinson's disease patient-derived induced pluripotent stem cells free of viral reprogramming factors |
|
| Partial FMRP expression is sufficient to normalize neuronal hyperactivity in Fragile X neurons |
|
| Partial rescue of MeCP2 deficiency by postnatal activation of MeCP2. |
|
| Partial reversal of Rett Syndrome-like symptoms in MeCP2 mutant mice |
|
| Passive immunotherapy prevents expression of endogenous Moloney virus and amplification of proviral DNA in BALB/Mo mice |
|
| Pharmacological enhancement of KCC2 gene expression exerts therapeutic effects on human Rett syndrome neurons and Mecp2 mutant mice |
|
| Phosphorylation of MeCP2 at Serine 80 regulates its chromatin association and neurological function. |
|
| Pluripotency and cellular reprogramming: facts, hypotheses, unresolved issues |
|
| Pluripotent stem cells are highly susceptible targets for syngeneic, allogeneic, and xenogeneic natural killer cells |
|
| Tailored humanity? |
|
| Transnuclear mice with pre-defined T cell receptor specificities against Toxoplasma gondii obtained via SCNT. |
|
| Tumorviruses, neoplastic transformation and differentiation / edited by T. Graf and R. Jaenisch. - Berlin, 1982. |
|
| Über infektiöse Substrukturen aus Escherichia coli-Bakteriophagen. 8 On the tertiary structure and biological properties of ∅ × 174 replicative form. [Teildr.] |
|
| 哺乳類初期胚の遺伝子操作 : 発生工学研究の現状と展望 |
|
